Home
 

> About Asthmatx
> Career Opportunities
> News & Events
> Media & Investor Relations

Our commitment to
excellence.


By radically changing the standard of care, Asthmatx will be the world leader in device-based solutions for patients with asthma.

FAQ
What is Asthma?
Asthma is a common disease in which the airways in the lung become inflamed, excess airway mucus is produced, and airways narrow when muscles within the airway walls contract.

Media and Investor Relations

Fact Sheets

About Asthmatx
About Bronchial Thermoplasty
About the AIR2 Trial

 

Logos and other Artwork

Please call or email our Media Contact below for our media kit

Media Contact

Karen Passafaro, VP Marketing
408-419-0118 phone
408-419-4695 fax
media@asthmatx.com

Investor Contact

Glen French, President & CEO
408-419-0100 phone
investors@asthmatx.com

Asthmatx is privately held.

To send us a message or request more information about Asthmatx or Bronchial Thermoplasty, click here

 

CAUTION: The Alair® System is an Investigational device. It is limited by United States law to investigational use. To be used by Qualified Investigators only.